Market Overview

Nelson Peltz Bubbles Excitement And Expresses Foreboding Over These Two Stocks

Share:
Nelson Peltz Bubbles Excitement And Expresses Foreboding Over These Two Stocks

Renowned activist investor and founder of hedge fund Trian Partners, Nelson Peltz, spoke at CNBC's 2015 Delivering Alpha conference on Wednesday.

At the conference, Peltz discussed his new positions with Jim Cramer, including Pentair plc. Ordinary Share (NYSE: PNR). He also opined on losing the proxy fight against the board of E I Du Pont De Nemours And Co (NYSE: DD). Here is what he said.

New Positions

Peltz revealed that he has two new positions accounting for one-third of Trian Partners' current equity portfolio.

He was asked to reveal at least the sectors of the companies in which the fund has initiated new positions. He replied, "One is in industrial, which we've announced. That we had two industrials, one has been announced which is Pentair, which we are very excited about.

"The other one we have not categorized yet, we are going to leave it that way."

Related Link: Jeffrey Gundlach On Delivering Alpha: Apple, Chipotle And More

DuPont

On losing the proxy fight against DuPont's board, Peltz said, "It's been a significant loss for shareholders. Stock has gone from $80 – when I was on your show March 12; it was my wife's birthday that day – and the stock was $59 yesterday, and you can add $2 to that for Chemours. But, it's been a loss for all shareholders.

"And we had 46 percent of the vote, and the activists, the index funds voted against us."

Peltz continued, "But we haven't sold our shares; that's not our style. And we are going to wait and watch and see what the management and the board will do from here forward. And Ellen Kullman (DuPont CEO) was in my office last week, and I said to her, 'The second least favorite thing that I'd like to do is have another proxy fight, but the first least favorite thing I'd like to do is to see DuPont next year at this price,'" Peltz concluded.

Image Credit: Public Domain

Posted-In: Chemours CNBC Delivering Alpha Ellen Kullman Nelson Peltz pentairAnalyst Color Media

 

Related Articles (DD + PNR)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
BGNECLSADowngrades
SWKSMizuhoMaintains90.0
KEMB. Riley FBRDowngrades27.2
ROKGabelli & Co.Downgrades
SSRMB. Riley FBRUpgrades23.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Five Prime Therapeutics Establishes Strategic Research Collaboration and License Agreement With Inhibrx for Novel GITR Antibodies

Radiant Logistics Announces Proposed Public Offering Of Common Stock